Normal pressure hydrocephalus (NPH) is a neurological disorder characterized by ventricular enlargement despite normal cerebrospinal fluid (CSF) pressure, presenting with a triad of gait disturbance, cognitive impairment, and urinary incontinence. This page explores the vulnerable neuron populations affected in NPH and their contributions to the clinical manifestations of this treatable dementia. Understanding NPH is particularly relevant for neurodegenerative disease research, as it shares features with Alzheimer's disease (AD), Parkinson's disease (PD), and vascular dementia.
- Incidence: 1-2 per 100,000 in persons over 65 years
- Prevalence: Approximately 5% of all dementias in the elderly
- Age: Typically presents in the 7th-8th decade of life
- Risk factors: Advanced age, vascular disease, traumatic brain injury
- No identifiable cause
- Most common form
- Often called "treatable dementia"
- Following traumatic brain injury
- After neurosurgery
- Due to meningitis or hemorrhage
- Associated with subarachnoid hemorrhage
| Taxonomy |
ID |
Name / Label |
| Cell Ontology (CL) |
CL:4042028 |
immature neuron |
- Morphology: immature neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
The lateral ventricles are lined by several neuron populations that are directly affected by ventricular enlargement:
- Function: CSF-brain barrier, CSF circulation
- Damage: Compression and flattening
- Consequence: Impaired CSF dynamics
- Function: Adult neurogenesis
- Damage: Disruption of neurogenic niche
- Consequence: Impaired neuronal regeneration
- Affected: Preoptic area, supraoptic nucleus
- Symptoms: Autonomic dysfunction, circadian disruption
Executive dysfunction in NPH reflects prefrontal cortical pathology:
- Function: Executive function, working memory
- Damage: White matter disconnection
- Symptoms: Planning, organization deficits
- Function: Decision-making, social behavior
- Damage: Compression from enlarged ventricles
- Symptoms: Apathy, disinhibition
- Function: Attention, motivation
- Damage: Associated white matter changes
- Symptoms: Apathy, decreased initiative
Memory impairment in NPH involves hippocampal dysfunction:
- Vulnerability: Particularly sensitive to compression
- Damage: Ischemia from altered perfusion
- Memory deficits: Encoding and retrieval
¶ Subiculum and Entorhinal Cortex
- Function: Gateway to hippocampus
- Damage: Early involvement
- Consequence: Spatial memory deficits
- Function: Pattern separation
- Damage: Reduced neurogenesis
- Memory symptoms: Confusion, disorientation
Gait disturbance in NPH reflects basal ganglia dysfunction:
¶ Striatum (Caudate and Putamen)
- Motor planning: Sequence learning, habit formation
- White matter changes: Disconnect cortical inputs
- Symptoms: Shuffling gait, reduced arm swing
- Motor inhibition: Output nucleus of basal ganglia
- Damage: Compression from dilated ventricles
- Symptoms: Bradykinesia, rigidity (mimicking PD)
- Dopaminergic neurons: Vulnerable to compression
- Damage: May explain parkinsonian features
- Overlap with PD: Some patients respond to dopaminergic therapy
Autonomic dysfunction in NPH involves brainstem pathology:
- Function: Bladder control
- Damage: Compression from fourth ventricle
- Symptoms: Urinary urgency, frequency, incontinence
- Function: Arousal, attention
- Damage: Noradrenergic dysfunction
- Symptoms: Cognitive slowing, attention deficits
- Autonomic control: Parasympathetic regulation
- Damage: Contributes to autonomic failure
- Symptoms: Cardiovascular instability
- Arachnoid granulations: Reduced absorption capability
- Aqueductal obstruction: Partial blockage
- Venous insufficiency: Reduced CSF clearance
- Compressive effects: Direct neuronal injury
- White matter edema: Ischemic damage
- Vascular compromise: Periventricular hypoperfusion
- White matter ischemia: Reduced blood flow
- Myelin loss: Demyelination
- Axonal damage: Disconnection syndromes
- Compromised perfusion: Altered autoregulation
- Metabolic stress: Reduced glucose uptake
- Oxidative damage: Mitochondrial dysfunction
- Astrocyte reactivity: A1 phenotype
- Microglial activation: Pro-inflammatory cytokines
- Blood-brain barrier disruption: Increased permeability
- Tau pathology: AD-like changes in some patients
- Amyloid deposition: Variable
- Synaptic loss: Reduced dendritic complexity
- Overlap: Cognitive impairment, hippocampal atrophy
- Differences: NPH has prominent gait disturbance early
- Imaging: Ventricular enlargement more uniform in NPH
- CSF biomarkers: May help distinguish
- Overlap: Gait disturbance, autonomic dysfunction
- Differences: NPH lacks resting tremor
- DaTscan: Normal in NPH
- Response to levodopa: Variable in NPH, good in PD
- Overlap: White matter changes, cognitive impairment
- Differences: NPH has prominent gait first
- Imaging: NPH has more uniform ventricular enlargement
- History: Stroke more common in vascular dementia
- Gait disturbance: Magnetic gait, shuffling
- Cognitive impairment: Executive dysfunction, apathy
- Urinary incontinence: Urgency, frequency
- Ventricular enlargement: Dilated lateral and third ventricles
- Periventricular hyperintensities: White matter changes
- Callosal angle: <90 degrees on coronal T2
- CSF flow voids: Disproportionate to pressure
- Ventricular enlargement: Evans index >0.3
- Periventricular hypodensities: White matter ischemia
- Opening pressure: Normal (70-180 mm H2O)
- Tap test: Temporary improvement after CSF removal
- External lumbar drainage: More definitive diagnostic
¶ Treatment and Neuronal Recovery
- Gold standard: Most effective treatment
- Mechanism: Divert excess CSF
- Outcomes: 70-80% improvement
- Recovery: Neuronal function can improve
- Alternative: For certain patients
- Complications: Lower intracranial pressure symptoms
- Alternative: For selected patients
- Mechanism: Bypass CSF blockage
- Acetazolamide: Carbonic anhydrase inhibitor
- Diuretics: Reduce CSF production
- Cognitive enhancers: Temporary benefit
- Physical therapy: Maintain function
- Age: Younger patients do better
- Duration: Shorter duration predicts better response
- Gait predominance: Gait-first has better prognosis
- Comorbidities: Vascular disease reduces success
- Neuronal recovery: Possible with shunt
- White matter recovery: Partial
- Cognitive improvement: 40-60% improve
- Gait improvement: Best outcome, 60-80%
The study of Neurons In Normal Pressure Hydrocephalus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.